These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modulation of drug transporters at the blood-brain barrier. Fricker G; Miller DS Pharmacology; 2004 Apr; 70(4):169-76. PubMed ID: 15001817 [TBL] [Abstract][Full Text] [Related]
5. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. Kusuhara H; Sugiyama Y Drug Metab Pharmacokinet; 2009; 24(1):37-52. PubMed ID: 19252335 [TBL] [Abstract][Full Text] [Related]
6. Drug disposition and targeting. Transport across the blood-brain barrier. Rochat B; Audus KL Pharm Biotechnol; 1999; 12():181-200. PubMed ID: 10742975 [No Abstract] [Full Text] [Related]
7. Drug transport in intestine, liver and kidney. Schwenk M Arch Toxicol; 1987; 60(1-3):37-42. PubMed ID: 3304216 [TBL] [Abstract][Full Text] [Related]
8. The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs. Kusuhara H; Suzuki H; Sugiyama Y J Pharm Sci; 1998 Sep; 87(9):1025-40. PubMed ID: 9724551 [No Abstract] [Full Text] [Related]
9. Use of in vitro transporter assays to understand hepatic and renal disposition of new drug candidates. Sahi J Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):409-27. PubMed ID: 16863453 [TBL] [Abstract][Full Text] [Related]
10. Opioids, transporters and the blood--brain barrier. Sweeney BP; Grayling M Eur J Anaesthesiol; 2005 Jul; 22(7):489-91. PubMed ID: 16045135 [No Abstract] [Full Text] [Related]
11. Organic Anion Transporter 2: An Enigmatic Human Solute Carrier. Shen H; Lai Y; Rodrigues AD Drug Metab Dispos; 2017 Feb; 45(2):228-236. PubMed ID: 27872146 [TBL] [Abstract][Full Text] [Related]
12. Transporters and xenobiotic disposition. Kim RB Toxicology; 2002 Dec; 181-182():291-7. PubMed ID: 12505328 [TBL] [Abstract][Full Text] [Related]
13. Aluminum citrate uptake by immortalized brain endothelial cells: implications for its blood-brain barrier transport. Yokel RA; Wilson M; Harris WR; Halestrap AP Brain Res; 2002 Mar; 930(1-2):101-10. PubMed ID: 11879800 [TBL] [Abstract][Full Text] [Related]
14. Membrane permeability in the gastrointestinal tract: the interplay between microclimate pH and transporters. Kristl A Chem Biodivers; 2009 Nov; 6(11):1923-32. PubMed ID: 19937830 [TBL] [Abstract][Full Text] [Related]
15. The role of drug transporters at the blood-brain barrier. de Boer AG; van der Sandt IC; Gaillard PJ Annu Rev Pharmacol Toxicol; 2003; 43():629-56. PubMed ID: 12415123 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084 [TBL] [Abstract][Full Text] [Related]
18. Active efflux across the blood-brain barrier: role of the solute carrier family. Kusuhara H; Sugiyama Y NeuroRx; 2005 Jan; 2(1):73-85. PubMed ID: 15717059 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of xenobiotic detoxification system mediated by efflux transporters]. Suzuki H Yakugaku Zasshi; 1999 Nov; 119(11):822-34. PubMed ID: 10590710 [TBL] [Abstract][Full Text] [Related]
20. Transporters and renal drug elimination. Lee W; Kim RB Annu Rev Pharmacol Toxicol; 2004; 44():137-66. PubMed ID: 14744242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]